{"status": "OK", "response": {"docs": [{"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: In ''Thousands Died in Africa Yesterday'' (editorial, Feb. 27), you point out that ''when it comes to Africa, where hundreds of thousands of poor men, women and children die needlessly each year from preventable diseases, or unnatural disasters like civil wars, much of the developed world seems to have a heart of stone.'' Of the world's 50 least-developed countries, 34 are in Africa. As a group, they remain marginalized in the world economy and continue to suffer from extreme poverty.", "headline": {"main": "The Poorest Countries"}, "abstract": "UN Under Sec Anwarul K Chowdhury letter holds that least-developed countries, particularly those in Africa, face challenge of huge, unsustainable debt service payment; says their economic growth and development are stunted; contends that only full debt cancellation will free resources needed for investment in health and education and for fulfilling basic needs of their people", "print_page": "12", "word_count": 233, "_id": "4fd247818eb7c8105d7e2d91", "snippet": "To the Editor:     In ''Thousands Died in Africa Yesterday'' (editorial, Feb. 27), you point out that ''when it comes to Africa, where hundreds of thousands of poor men, women and children die needlessly each year from preventable diseases, or...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9501E0D9113DF935A35750C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CHOWDHURY, ANWARUL K"}, {"name": "glocations", "value": "AFRICA"}, {"name": "subject", "value": "EDUCATION AND SCHOOLS"}, {"name": "subject", "value": "CREDIT"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "ECONOMIC CONDITIONS AND TRENDS"}, {"name": "subject", "value": "THIRD WORLD AND DEVELOPING COUNTRIES"}], "byline": null, "document_type": "article", "pub_date": "2005-03-06T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A federal advisory panel began wrestling yesterday with whether to remove from the market a lung cancer drug that was rapidly approved for use by desperate patients but has now failed to prolong lives in a large clinical trial. The advisory panel to the Food and Drug Administration was not asked to vote on the fate of the drug, Iressa, which is made by AstraZeneca. Agency officials said they would await more data before making any decision.", "headline": {"main": "F.D.A. Panel Weighs Fate Of a Drug For Cancer"}, "abstract": "Food and Drug Administration advisory panel is considering whether to remove from market Iressa, lung cancer drug made by AstraZeneca that was rapidly approved for desperate patients but has failed to prolong lives in large clinical trial; case of Iressa has raised questions about whether FDA's accelerated approval program might be allowing ineffective or unsafe drugs on market (M)", "print_page": "8", "word_count": 778, "_id": "4fd2571f8eb7c8105d80175a", "snippet": "A federal advisory panel began wrestling with whether to remove from the market a lung cancer drug that has failed to prolong lives in a large clinical trial.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/05/politics/05fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "ASTRAZENECA PLC"}, {"name": "organizations", "value": "ASTRAZENECA"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "IRESSA (DRUG)"}, {"name": "subject", "value": "LUNGS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2005-03-05T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Review", "blog": [], "news_desk": "Leisure/Weekend Desk", "lead_paragraph": "'The Great Mortality' ''An Intimate History of the Black Death, the Most Devastating Plague of All Time'' By John Kelly 364 pages. HarperCollins. $25.95. The images could have come from one of Hieronymus Bosch's nightmarish paintings of hell: dusty roads filled with frightened refugees, many of them already ill, covered in boils and coughing up blood; dogs and rats running wild on deserted streets; fields littered with the dead bodies of cows and sheep; plague pits filled with the corpses of men, women and children; survivors pointing accusatory fingers at Jews and Muslims and outsiders; others flagellating themselves in an effort to appease the heavens.", "headline": {"main": "A Death-Bringer That Ushered In a New Way of Life", "kicker": "BOOKS OF THE TIMES"}, "abstract": "Michiko Kakutani reviews book The Great Mortality: An Intimate History of the Black Death, the Most Devastating Plague of All Time by John Kelly; photo (M)", "print_page": "41", "word_count": 800, "_id": "4fd25ae58eb7c8105d80781a", "snippet": "John Kelly gives the reader a ferocious, pictorial account of the horrific ravages of the Black Death.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/04/books/04BOOK.html", "multimedia": [{"url": "images/2005/03/03/books/kelly75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/03/03/books/kelly75.jpg"}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "legacy": {"tinythumbwidth": 55, "tinythumbheight": 55, "hastinythumb": "Y"}, "type": "image", "width": 55, "height": 55}], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "GREAT MORTALITY, THE: AN INTIMATE HISTORY OF THE BLACK DEATH, THE MOST DEVASTATING PLAGUE OF ALL TIME (BOOK)"}, {"name": "creative_works", "value": "GREAT MORTALITY, THE (BOOK)"}, {"name": "persons", "value": "KELLY, JOHN"}, {"name": "glocations", "value": "EUROPE"}, {"name": "subject", "value": "REVIEWS"}, {"name": "subject", "value": "BOOKS AND LITERATURE"}, {"name": "subject", "value": "HISTORY"}, {"name": "subject", "value": "PLAGUE"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Michiko", "rank": 1, "lastname": "KAKUTANI"}], "original": "By MICHIKO KAKUTANI"}, "document_type": "article", "pub_date": "2005-03-04T00:00:00Z", "section_name": "Arts; Books"}, {"type_of_material": "Obituary; Biography", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Dr. J. Donald M. Gass, an ophthalmologist whose keen observations led to diagnoses of previously undiscovered diseases of the retina, died last Saturday at his home in Nashville. He was 76. The cause was pancreatic cancer, his family said.", "headline": {"main": "J. Donald M. Gass, 76, a Leading Ophthalmologist"}, "abstract": "Dr J Donald M Gass, ophthalmologist whose work led to diagnosis of previously undiscovered diseases of retina, dies at age 76; photo (M)", "print_page": "19", "word_count": 549, "_id": "4fd2a5e18eb7c8105d88dd29", "snippet": "Dr. J. Donald M. Gass was an ophthalmologist whose keen observations led to diagnoses of previously undiscovered diseases of the retina.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/04/national/04gass.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GASS, J DONALD M"}, {"name": "glocations", "value": "NASHVILLE (TENN)"}, {"name": "subject", "value": "CATARACTS"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "DEATHS (OBITUARIES)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jeremy", "rank": 1, "lastname": "PEARCE"}], "original": "By JEREMY PEARCE"}, "document_type": "article", "pub_date": "2005-03-04T00:00:00Z", "section_name": "U.S.; Obituaries"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Doctors may no longer make house calls, but they are answering patient e-mail messages -- and being paid for it. In a move to improve efficiency and control costs, health plans and medical groups around the country are now beginning to pay doctors to reply by e-mail, just as they pay for office visits. While some computer-literate doctors have been using e-mail to communicate informally with patients for years, most have never been paid for that service.", "headline": {"main": "Digital Rx: Take Two Aspirins And E-Mail Me in the Morning"}, "abstract": "Health plans are beginning to pay doctors to answer patient e-mail messages, which can be efficient, convenient way for physicians and patients to discuss questions on diet, medication and other topics; patients may also use e-mail to secure Web sites to get test results and request prescription refills; several physicians patients comment; photos (M)", "print_page": "1", "word_count": 1697, "_id": "4fd2839f8eb7c8105d851ee5", "snippet": "Doctors may no longer make house calls, but they are answering patient e-mail messages - and being paid for it.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/02/technology/02online.html", "multimedia": [{"url": "images/2005/03/02/business/online.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/03/02/business/online.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "subject", "value": "ELECTRONIC MAIL"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "COMPUTERS AND THE INTERNET"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Milt", "rank": 1, "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2005-03-02T00:00:00Z", "section_name": "Technology; Front Page; Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "More than 700 scientists sent a petition on Monday to the director of the National Institutes of Health protesting what they said was the shift of tens of millions of dollars in federal research money since 2001 away from pathogens that cause major public health problems to obscure germs the government fears might be used in a bioterrorist attack. The scientists, including two Nobel Prize winners and a biologist who is to receive the National Medal of Science from President Bush in March, say grants for research on the bacteria that cause anthrax and five other diseases that are rare or nonexistent in the United States have increased fifteenfold since 2001. Over the same period, grants to study bacteria not associated with bioterrorism, including those causing diseases like tuberculosis and syphilis, have decreased 27 percent, the petition said.", "headline": {"main": "U.S. Germ-Research Policy Is Protested by 758 Scientists"}, "abstract": "More than 700 scientists send petition to National Institutes of Health director saying research grants on bacteria causing anthrax and other diseases rare in US have increased fifteenfold since 2001, and that this shift of millions of dollars in federal research money has decreased grants to study pathogens that cause major public health problems (M)", "print_page": "14", "word_count": 713, "_id": "4fd25df68eb7c8105d80c92d", "snippet": "The scientists sent a petition to the director of the National Institutes of Health protesting what they said was a shift in funding from pathogens that affect public health to obscure germs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/01/politics/01petition.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "NATIONAL INSTITUTES OF HEALTH"}, {"name": "subject", "value": "ANTHRAX"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "BACTERIA"}, {"name": "subject", "value": "SCIENCE AND TECHNOLOGY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Scott", "rank": 1, "lastname": "SHANE"}], "original": "By SCOTT SHANE"}, "document_type": "article", "pub_date": "2005-03-01T00:00:00Z", "section_name": "Technology; Science; Health; U.S."}, {"type_of_material": "Series", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "It was early February 2000, and Judge Paula J. Hepner said she could hardly believe what a doctor in the city's juvenile justice system had done to the girl standing before her in Brooklyn Family Court. The girl, Tiffany S., was 14, with a history of suicide threats and a set of serious psychological problems well documented by doctors at a psychiatric hospital for children. They had treated her bipolar disorder with powerful medicines and, knowing that she was facing detention, had recommended that she keep receiving them when the Department of Juvenile Justice took her into custody.", "headline": {"main": "A Spotty Record of Health Care For Children in City Detention"}, "abstract": "Last article in series Harsh Medicine focuses on mistreatment of troubled and needy children in New York City Juvenile Justice system while Prison Health Services was providing care from January 1999 to April 2003; evidence abounds of children being taken off psychiatric medicines that had proven effective and shifted to lower cost drugs, mostly with disastrous results; only one independent audit of Prison Health's performance was made and that was six months after company had been replaced; audit found records in disarray, mixups in medication and other grievous abuses, including lack of follow-up care for serious illnesses; audit was never made public; company had only one full-time doctor Ralph L Williams for 19 juvenile centers across city; audit shows doctors rarely consulted records; Williams made decision on medication and oversaw staff of mostly part-time physician assistants, social workers and nurses; while Juvenile Justice officials have said they were 'generally satisfied' with company, Comptroller William C Thompson calls work 'deplorable'; photos (L)", "print_page": "1", "word_count": 2856, "_id": "4fd2571f8eb7c8105d8016fc", "snippet": "Court records suggest that Prison Health Servicespoorly served many of the children in New York City's juvenile justice system.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/03/01/nyregion/01jail.html", "multimedia": [{"url": "images/2005/03/01/nyregion/jail.7575.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/03/01/nyregion/jail.7575.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "persons", "value": "WILLIAMS, RALPH L"}, {"name": "persons", "value": "THOMPSON, WILLIAM C JR"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "organizations", "value": "PRISON HEALTH SERVICES"}, {"name": "subject", "value": "CHILD CUSTODY AND SUPPORT"}, {"name": "subject", "value": "PRISONS AND PRISONERS"}, {"name": "subject", "value": "SURVEYS AND SERIES"}, {"name": "subject", "value": "PRIVATIZATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By PAUL von ZIELBAUER"}, "document_type": "article", "pub_date": "2005-03-01T00:00:00Z", "section_name": "Front Page; Health; New York and Region"}], "meta": {"hits": 7, "offset": 0, "time": 36}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}